fda bpc-157 category 2 compounding 2023 The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances pharmacies can make. Follow the link I am getting so many

I am getting so many messages there is a lot to review and a lot unfolding quickly! I want to take my time with the information and have been studying on rotations. Hopefully will get yall an only HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list reversing the 2023 crackdown that shut down compounding pharmacies and fueled A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! BREAKING: The peptide landscape just changed. The FDA advisory panel voted to recommend broader pharmacy compounding access for BPC 157, KPV, and TB 500. It's one of the biggest regulatory developments the peptide space

SKU: 65532545619 · From clintoncounty708.com